Case Report
Published on 28 Jun 2023
A meaningful exploration of ofatumumab in refractory NMOSD: a case report
in Multiple Sclerosis and Neuroimmunology
- 3,539 views
- 4 citations
Case Report
Published on 28 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 26 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 19 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Opinion
Published on 16 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 16 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 07 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 07 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 07 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 02 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 02 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 02 Jun 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 31 May 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 30 May 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 30 May 2023
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 26 May 2023
in Multiple Sclerosis and Neuroimmunology